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Background: Patients with myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) are 
unable to activate brain-orchestrated endogenous analgesia (or descending inhibition) in response 
to exercise. This physiological impairment is currently regarded as one factor explaining post-
exertional malaise in these patients. Autonomic dysfunction is also a feature of ME/CFS.
Objectives: This study aims to examine the role of the autonomic nervous system in exercise-
induced analgesia in healthy people and those with ME/CFS, by studying the recovery of autonomic 
parameters following aerobic exercise and the relation to changes in self-reported pain intensity.
Study Design: A controlled experimental study.
Setting: The study was conducted at the Human Physiology lab of the Vrije Universiteit Brussel.
Methods: Twenty women with ME/CFS- and 20 healthy, sedentary controls performed a 
submaximal bicycle exercise test known as the Aerobic Power Index with continuous cardiorespiratory 
monitoring. Before and after the exercise, measures of autonomic function (i.e., heart rate variability, 
blood pressure, and respiration rate) were performed continuously for 10 minutes and self-reported 
pain levels were registered. The relation between autonomous parameters and self-reported pain 
parameters was examined using correlation analysis.
Results: Some relationships of moderate strength between autonomic and pain measures were 
found. The change (post-exercise minus pre-exercise score) in pain severity was correlated (r = .580, 
P = .007) with the change in diastolic blood pressure in the healthy group. In the ME/CFS group, 
positive correlations between the changes in pain severity and low frequency (r = .552, P = .014), 
and between the changes in bodily pain and diastolic blood pressure (r = .472, P = .036), were seen. 
In addition, in ME/CHFS the change in headache severity was inversely correlated (r = -.480, P = 
.038) with the change in high frequency heart rate variability.
Limitations: Based on the cross-sectional design of the study, no firm conclusions can be drawn 
on the causality of the relations.
Conclusions: Reduced parasympathetic reactivation during recovery from exercise is associated 
with the dysfunctional exercise-induced analgesia in ME/CFS. Poor recovery of diastolic blood 
pressure in response to exercise, with blood pressure remaining elevated, is associated with 
reductions of pain following exercise in ME/CFS, suggesting a role for the arterial baroreceptors in 
explaining dysfunctional exercise-induced analgesia in ME/CFS patients.
Key words: Aerobic exercise, aerobic power index, autonomic nervous system, exercise-induced 
analgesia, exercise-induced hypoalgesia, fibromyalgia, heart rate variability, stress-induced analgesia, 
pain
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It has been reported that aerobic exercise causes an acute analgesic effect in healthy people (1,2). Increased pain thresholds and pain tolerance, as 
well as lower pain ratings, have been found to occur 
following exercise (3). Depending on the exercise 
intensity and duration these reductions in pain 
perception can last up to 30 minutes post-exercise (1). 
Patients with myalgic encephalomyelitis/chronic fatigue 
syndrome (ME/CFS), a condition characterized by severe 
fatigue, widespread pain, cognitive impairments, and 
delayed recovery following exercise (4-6), are unable 
to activate brain-orchestrated endogenous analgesia 
(or descending inhibition) in response to exercise (7-9). 
This physiological impairment is currently regarded as 
one factor explaining post-exertional malaise in these 
patients.
At present, the precise mechanisms of this stress or 
exercise-induced analgesia (EIA) are unknown. It has 
been hypothesized that the cardiovascular and the hor-
monal system could be responsible for this mechanism. 
This comes as no surprise as it is well known that the 
sympathetic branch of the autonomic nervous system 
and the hypothalamic-pituitary-adrenal axis (HPA-axis) 
are activated during exercise and that there is a mutual 
stimulatory interaction between these 2 systems (10,11). 
(Nor)adrenaline and cortisol are major end products of 
the sympathetic nervous system and the HPA-axis, re-
spectively. In addition to their effects as stress hormones, 
they have strong analgesic effects in the central nervous 
system (i.e., as brain neurotransmitters and acting on 
the dorsal horn neurons) (12).
Many studies have examined the possible interac-
tion between the cardiovascular system and exercise-
induced changes in pain. Exercise is accompanied with 
dynamic changes in cardiac responses which result in an 
increased blood flow and a redistribution of the blood 
to satisfy the energy demands of the working muscles. 
These cardiodynamic changes are induced by sympa-
thetic activation and parasympathetic withdrawal (13). 
It is thought that the increases in heart rate and blood 
pressure during exercise will activate the arterial baro-
receptors, which is associated with the release of pain 
relieving neurotransmitters and peptides and the acti-
vation of pain modulatory regions in the brain (14-16). 
This hypothesis is based on observations from animal 
studies, and there is no direct and conclusive evidence 
for this theory in humans. 
It has also been reported that through blood pres-
sure increases, growth hormones and β-endorphins are 
released by the HPA-axis which in turn will activate 
opioid receptors and lead to analgesia (17). However 
previous studies were not able to confirm this theory 
(18,19). But there is evidence supporting the role of the 
hormonal system in EIA as observed in humans. It has 
been shown that during aerobic exercise the release 
of adrenocorticotropic hormone (ACTH) increases, 
and that this is associated with increased dental pain 
thresholds (20). When the release of ACTH during 
exercise is experimentally limited, this also limits the 
magnitude of pain threshold increases. As hormones 
such as ACTH are released by the HPA-axis, it seems 
that this physiological stress system plays an important 
role in the phenomenon of EIA. Furthermore, in order 
to recover from exercise and restore homeostasis, the 
HPA-axis will be activated, which results in increased 
post-exercise cortisol production and enhanced vagal 
activity to restore the balance between the sympathetic 
and parasympathetic nervous system (21). 
While the role of the hormonal system in EIA has 
been previously studied by determining hormone 
concentrations in saliva and blood samples, to our 
knowledge, no studies have examined the relationship 
between exercise-induced changes in pain and auto-
nomic function. This would be of particular relevance 
for unraveling the dysfunctional EIA in ME/CFS. Au-
tonomic dysfunction is an established feature of ME/
CFS (22-24) and has been linked repeatedly to the in-
ability of ME/CFS-patients to perform or recover from 
exercise/physical activity (9,25,26). Hence, the purpose 
of this study was to examine the role of autonomic 
function in EIA in healthy sedentary (HS) controls and 
ME/CFS patients. It was hypothesized that in healthy 
people the sympatho/vagal balance would have been 
restored during recovery from exercise, while this 
would not be the case in ME/CFS, and that this ability 
to recover from exercise would be associated with the 
degree of EIA.
Methods
Participants
Twenty HS women and 20 women with ME/CFS 
participated in this study. Patients diagnosed with ME/
CFS following the 1994 Center for Disease Control and 
Prevention criteria (27) were recruited from the patient 
databases from the department of internal medicine 
at a university hospital, and from a private practice for 
internal medicine. The HS group was a convenience 
sample consisting of healthy friends and relatives from 
the ME/CFS patients and volunteers who replied to ad-
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at the familiarization session. Participants filled out 
a questionnaire to collect sociodemographic/disease 
related information and the Hospital Anxiety and 
Depression Scale (HADS) (30). One of the researchers 
(JVO) measured participants’ weight and height, and 
although not an inclusion criterion, it was examined 
whether the included patients also fulfilled the more 
recent Canadian criteria for ME/CFS (31), which was the 
case for all patients. To prevent stress on the day of the 
experiment due to the unfamiliar environment, each 
participant was guided through the lab, the full test 
procedure was explained, and the different assessment 
methods and materials were shown and tried out. Prior 
to leaving, an accelerometer (Actical, Mini Mitter, USA) 
was attached to the wrist of the non-dominant hand 
and participants were asked to wear it continuously for 
at least 6 full days to measure their daily activity levels 
(32-34). The second visit was scheduled to take place 
within a range of 7 – 21 days following the first visit. 
The procedures are summarized in Fig. 1.
Experimental Session
The experiments took place in an acclimatized 
room with at constant ambient temperature between 
21 and 23°C.
Exercise Testing
The Aerobic Power Index is a standardized reliable 
and valid submaximal exercise test for both ME/CFS 
patients and HS people and has been previously used 
to document the lack/presence of EIA in these popula-
tions (9,35,36). The test was performed as described in 
vertisements. Healthy volunteers with a medical history 
of endocrine, immune, cardiovascular, or autonomic 
abnormalities were excluded. Sedentary was defined as 
having a seated occupation and performing ≤ 3 hours of 
moderate physical activity/week (28). To prevent sources 
of bias or confounding factors 1) only women, 2) aged 
between 18 and 65 years old, 3) who were not preg-
nant, lactating, or > 1 year postnatal were included, and 
4) participants were asked to refrain from consuming 
caffeine, alcohol, nicotine, and physical exertion on the 
day of the experiments, 5) ME/CFS patients were asked 
(if medically permissible) to abstain from medication 
acting on the cardiovascular system on the day of the 
experiments and from medication acting on the central 
nervous or hormonal systems at least 48 hours prior to 
the experiments.
An a priori sample size calculation was based on a 
similar study (29) which evaluated autonomic dysfunc-
tion in response to a submaximal bicycle exercise test 
in women with chronic stroke, as no studies in ME/CFS 
were available, and on a study (9) which used a sub-
maximal bicycle exercise test to evaluate EIA in women 
with ME/CFS. The calculations revealed that 16 to 21 
participants/group were required to obtain a power of 
.80 with α = .05.
All participants took part in a familiarization ses-
sion and an experimental session.
Familiarization Session
All procedures were approved by the local Ethics 
Committee of the University Hospital Brussels/Vrije Uni-
versiteit, and participants provided informed consent 
Fig. 1. Schematic of  the experimental procedures.
ECG: electrocardiogram, RR: respiratory rate, BP: blood pressure
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our previous study (9). In summary, cycling started at a 
workload of 25 watt (W)/minute and a pedaling rate of 
70 rotations/minute, and linearly increased with 25 W/
minute until 75% of the age predicted maximal heart 
rate (HR) was achieved (37). 
Continuous cardiorespiratory monitoring was 
performed using a portable cardiopulmonary indirect 
breath-by-breath calorimetry system (MetaMax 3B, 
Cortex Biophysik, Germany) and electrocardiographic 
(ECG) sensors connected to the Nexus-10 system (Mind 
Media BV, The Netherlands).
Immediately following the exercise test, the mask 
was removed and the participant was asked to rate 
their perceived exertion (RPE) using the Borg scale (39). 
Physiological Measures of Autonomic 
Function
Prior to exercise testing (at rest) and during the 
subsequent recovery period, physiological measures 
of autonomic function were performed. Autonomic 
modulation of HR variability and respiration rate were 
measured using the Nexus-10 wireless and portable 
telemetry data acquisition system and analyzed of-
fline with the BioSig toolbox in MATLAB software (The 
MathWorks, USA). Measures were taken continuously 
during 10 minutes of quiet supine lying, and the means 
of these 10 minute periods were calculated and used 
for further analysis.
ECG was performed to measure HR variability 
(HRV). The root mean square of successive differences 
between the beat-to-beat or NN intervals (RMSSD) was 
calculated. Frequency analysis of HRV was performed 
using the quotient (HRV LF/HF ratio) of low-frequency 
components (i.e., the power in the low frequency [LF] 
range between 0.04 – 0.15Hz) over high-frequency 
components (i.e., the power in the high frequency [HF] 
range between 0.15 – 0.40Hz) after fast Fourier trans-
formation (39,40). 
Respiration rate (RR) was measured with an elastic 
belt which was placed around the chest (Fig. 1) and in-
cluded a piezoelectric sensor responsive to stretch. Peak 
detection was applied, and the RR was defined as the 
number of peaks per minute.
Blood pressure (BP) was measured at the start 
and at the end of the 10 minute periods preceding 
and following the exercise test using an electronic BP 
monitor (Bosi medicus, BOSCH + SOHN GHMB U.CO.KG, 
Germany). The inflatable cuff was placed around the 
left upper arm, which was supported and positioned at 
heart level.
Self-reported Measures of Pain
EIA was assessed using self-reported pain mea-
sures, which were presented in random order to the 
participants prior to and following the exercise test and 
the autonomic measures.
Pain (muscle and/or joint pain) and headache inten-
sity were assessed using a visual analogue scales (VAS). A 
VAS is a continuous scale comprised of a horizontal line 
which measures 100 mm with the left outer end labeled 
as no pain or headache at all and the right outer end 
labeled as unbearable pain or headache. The VAS is the 
most commonly used tool to evaluate pain (41).
The SF-36 bodily pain subscale consists of 2 items 
which assess bodily pain intensity and interference of 
pain with normal activities (41). A score between 0 – 
100 is obtained on the subscale, and a higher score 
indicates lack of bodily pain. The SF-36 is reliable and 
valid in a wide variety of patient populations (42-44) 
and appears to be the most frequently used measure in 
ME/CFS research (45). 
Statistical Analysis
Statistical analyses were conducted using SPSS ver-
sion 20.0 (IBM Corporation, USA) and the significance 
level was set at .05. Descriptives were calculated and 
normality of the data was evaluated using the Shapiro-
Wilk test and visual assessment of the histograms, QQ-
plots, and boxplots. When possible outliers were identi-
fied using this method, it was examined whether these 
were in the normal range of the according measures 
or whether they were considered as outliers using the 
outlier labeling rule (46).
Comparability of the groups at baseline and re-
garding exercise response was examined using the In-
dependent Samples T test or the Mann-Whitney U test. 
The Fisher exact test or the Pearson Chi-Square test was 
used to analyze binary and categorical data. A linear 
mixed model analysis with 2 factors, i.e., group (ME/
CFS vs. HS) and time (day 1, day 2, day 3, day 4, day 5, 
day 6), was conducted to examine potential differences 
regarding daily physical activity levels. When required, 
post-hoc comparisons were made and adjusted using 
the Bonferroni-correction.
For each group (ME⁄CFS and HS) possible differ-
ences in the response of each of the outcome measures 
to exercise was examined using the Paired Samples T 
test or the Wilcoxon Signed Rank test.
The changes in self-reported measures of pain and 
outcome measures of autonomic function in response 
to the exercise were calculated (Δ = post-exercise minus 
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pre-exercise scores), and bivariate Spearman and Pear-
son correlation analyses were performed to examine 
the relationship between autonomic function and EIA.
Results
Participants
Sociodemographic characteristics were comparable 
between groups as shown in Table 1. HADS scores indi-
cated that there were no significant group differences 
regarding levels of anxiety, while the ME/CFS patients 
reported significantly higher levels of depression than 
HS participants.
The mean time from diagnosis reported by the pa-
tients was 70.3 months (ranging from 1 to 162 months, 
median 63.5 months). Even though participants were 
asked to refrain from central acting medication on the 
day of exercise testing, 6 ME/CFS patients and one HS 
participant reported using medication. However, only 2 
ME/CFS patients took central acting selective serotonin 
reuptake inhibitors, while all other participants took 
peripheral acting drugs including paracetamol, diclof-
Table 1. Demographic baseline characteristics.
CFS/ME group
(n=20)
HS group
(n=20)
Between group comparison 
(P-value)
Age, years
Mean (SD) 41.6 (9.8) 34.6 (15.2)
.155
BMI
Mean (SD) 26 (6) 24 (4)
.245
Activity levels, AC
Mean AC day 1 (SD)
Mean AC day 2 (SD)
Mean AC day 3 (SD)
Mean AC day 4 (SD)
Mean AC day 5 (SD)
Mean AC day 6 (SD)
Mean AC over 6 days (SD)
275 (31)
222 (31)
220 (31)
239 (31)
221 (31)
218 (31)
233 (27)
320 (30)
322 (30)
368 (30)
335 (30)
342 (30)
318 (31)
334 (26)
.083
.010
Employment status 
Student (n)
Retired (n)
Full-time (n)
Part-time (n)
Non-employed (n)
1
0
4
6
9
7
1
2
4
6
.127
Years of education
Mean (SD) 14.4 (2.8) 15.6 (2.7)
.177
Highest degree of education
Primary school (n)
Secondary education (n)
Higher education - university or college (n)
Higher education - adult education social 
Advancement course (n)
0
12
8
0
0
5
15
0
.054
Marital status
Single (n)
Living together (n)
Married (n)
Widow (n)
9
2
8
1
12
1
7
0
.609
Children 
Yes
No
Mean number (SD)
7
13
1.1 (1.0)
12
8
1.0 (1.3)
.205
.601
HADS, score
Anxiety, mean (SD)
Depression, mean (SD)
11.2 (5.6)
10.7 (5.3)
9.1 (7.2)
6.2 (6.6)
.180
.023
ME/CFS, Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS). HS, healthy sedentary. SD, standard deviation. n, number of. AC, 
activity counts.
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enac, and non-steroid anti-inflammatory drugs which 
were allowed. Nevertheless, there were no significant 
between group (P = .091) differences regarding medi-
cation use.
No significant group differences were found 
regarding daily physical activity levels or possible day-
to-day fluctuations (time*group P = .083). When the 
mean activity counts over 6 days were compared, ME/
CFS patients were significantly less active compared 
with HS controls (P = .010). However, this did not af-
fect exercise performance or exercise capacity, as there 
were no significant group differences regarding these 
outcome measures.
Group Differences and Exercise Response
All participants were able to complete the exercise 
test, and there were no significant differences between 
the groups regarding theoretical target HR (P = .149, 
ME/CFS 134 ± 7 bpm, HS 140 ± 12 bpm), actual achieved 
peak HR (P = .453, ME/CFS 140 ± 9 bpm, HS 142 ± 10 
bpm), actual achieved mean HR (P = .092, ME/CFS 114 
± 10 bpm, HS 119 ± 10 bpm), cycling time (P = .401, 
ME/CFS 3.86 ± 1 min, HS 4.15 ± 1.15 min), maximum 
workload achieved (P = .327, ME/CFS 109 ± 25 W, HS 
118 ± 25 W), mean peak oxygen uptake (VO2peak) (P 
= .112, ME/CFS 16.98 ± 4.25 mL/min/kg, HS 19.96 ± 6.80 
mL/min/kg), mean peak ventilation (VEpeak) (P = .758, 
ME/CFS 31.81 ± 9.67 l/min, HS 31.61 ± 11.30 l/min), and 
peak respiratory exchange ratio (RERpeak) (P = .101, 
ME/CFS .76 ± .89, HS .72 ± .08). Although both groups 
performed a similar exercise test and showed similar ex-
ercise capacity, the average exercise load was perceived 
as “somewhat hard” by the HS group (RPE 12 ± 2) and 
“very heavy” (RPE 16 ± 3) by the ME/CFS patients (be-
tween group P < .001).
 Results of self-reported measures of pain are 
shown in Table 2. All these outcome measures indicated 
the presence of significantly higher pain complaints 
in the ME/CFS group compared to the HS group at 
baseline as well as following exercise. In the HS group 
the VAS scores for pain and headache decreased in re-
sponse to the exercise test, and the SF-36 bodily pain 
score increased, indicating that less pain complaints 
were experienced following exercise. However, only for 
VAS pain was the decrease large enough to reach sig-
nificance. In the ME/CFS group no significant changes 
were established. Comparing the Δ between groups 
confirmed previous observations of dysfunctional EIA 
(VAS pain P = .015, VAS headache P = .659, SF-36 bodily 
pain P = .758).
Results regarding within and between group 
changes in autonomic parameters are presented in 
Table 2. At baseline, BP, RR, and cardiac parameters 
in the time-domain were not significantly different 
between groups. Frequency-domain parameters LF 
and HF were significantly lower in the ME/CFS group 
compared to the HS group. The LF/HF ratio was similar 
between groups. In the HS group mean HR, RMSSD, HF, 
and LF/HF ratio did not significantly change following 
exercise, while LF significantly decreased. The ME/CFS 
group showed a significantly higher HR and lower HF 
following exercise, while RMSSD, LF, and LF/HF ratio 
remained unchanged. Both groups had higher RR fol-
lowing exercise and their systolic BP increased while 
diastolic BP remained stable. After 10 minutes of supine 
recovery, both systolic and diastolic BP were similar to 
the values seen at rest. There were no significant group 
differences regarding Δ (P < .05). Following exercise, 
there were no group differences regarding BP, RR, or 
mean HR. Significantly lower RMSSD, LF, and HF values, 
and a higher LF/HF ratio were seen post-exercise in the 
ME/CFS group compared to the HS group.
Correlation Analyses
As displayed in Table 3, Δ VAS pain was strongly 
correlated with Δ diastolic BP in the HS group. In the 
ME/CFS group, strong positive correlations between 
the Δ VAS pain and Δ LF, and between Δ SF-36 bodily 
pain and Δ diastolic BP, were seen. In addition, Δ VAS 
headache had a strong, inverse relationship with Δ HF.
discussion
This is the first study examining the role of auto-
nomic (dys)function in EIA. The dysfunctional EIA in 
the ME/CFS group was shown to be associated with 
reduced parasympathetic reactivation during recovery 
from exercise. In addition, poor recovery of diastolic 
BP in response to exercise, with BP remaining elevated, 
was associated with reductions of pain following exer-
cise. The latter finding suggests a role for the arterial 
baroreceptors in explaining dysfunctional EIA in ME/
CFS patients.  
We hypothesized that in healthy people the sym-
patho/vagal balance would have been restored during 
recovery from exercise, which was the case for all au-
tonomous parameters except LF. Although LF was not 
fully restored to pre-exercise values, the magnitude of 
(para)sympathetic activity cannot be as easily isolated 
from LF. The LF/HR ratio is a more adequate parameter 
to provide insight regarding sympatho/vagal balance 
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Table 2. Mean and standard deviations of  self-reported pain and autonomic outcome measures.
ME/CFS
(mean ± SD)
HS
(mean ± SD)
Between group comparison: 
ME/CFS vs HS (P-value)
VAS pain (muscle and/or joint pain) (mm)
pre-exercise
post-exercise
50.0 ± 31.3
50.0 ± 30.6
16.0 ± 21.2
5.2 ± 7.3
<.001
<.001
Within group comparison: pre vs post .423 .001
VAS headache (mm)
pre-exercise
post-exercise
34.5 ± 32.5
39.7 ± 29.4
3.6 ± 7.4
3.3 ± 5.5
<.001
<.001
Within group comparison: pre vs post .930 .609
SF-36 bodily pain (score)
pre-exercise
post-exercise
43.5 ± 18.1
45.0 ± 17.7
84.4 ± 14.1
85.2 ± 14.6
<.001
<.001
Within group comparison: pre vs post .695 .829
HR (bpm)
pre-exercise
post-exercise
71.33 ± 7.47
73.81 ± 8.56
71.78 ± 9.78
72.59 ± 8.32
.870
.655
Within group comparison: pre vs post .031 .578
HRV RMSSD (ms)
pre-exercise
post-exercise
27.25 ± 14.70
22.32 ± 9.98
42.51 ± 30.41
45.34 ± 29.20
.060
.010
Within group comparison: pre vs post .059 .881
HRV LF (ms2)
pre-exercise
post-exercise
234.06 ± 240.09
179.03 ± 181.63
470.35 ± 538.60
343.35 ± 286.72
.038
.015
Within group comparison: pre vs post .126 .012
HRV HF (ms2)
pre-exercise
post-exercise
169.53 ±166.5
101.24 ± 81.67
519.25 ± 772.93
513.43 ± 576.86
.024
.001
Within group comparison: pre vs post .044 .709
HRV LF/HF ratio
pre-exercise
post-exercise
1.92 ± 1.39
2.01 ± 1.21
1.48 ± 1.20
1.33 ± 1.12
.314
.035
Within group comparison: pre vs post .841 .502
RR (/min)
pre-exercise
post-exercise
15.74 ± 4.18
17.93 ± 3.81
17.93 ± 3.81
16.15 ± 3.23
.656
.343
Within group comparison: pre vs post .003 .005
Systolic BP (mmHg)
10 min pre-exercise
immediate post-exercise
10 min post-exercise
113.00 ± 12.35
119.80 ± 14.59
113.60 ± 12.80
110.55 ± 11.66
117.55 ± 11.33
113.50 ± 10.38
.523
.589
.979
Within group comparison: 10 min pre vs immediate post .001 .003
Within group comparison: 10 min pre vs 10 min post .698 .063
Diastolic BP (mmHg)
10 min pre-exercise
immediate post-exercise
10 min post-exercise
71.10 ± 6.89
72.20 ± 7.80
72.45 ± 7.11
69.50 ± 8.86
70.85 ± 7.82
70.70 ± 7.91
.528
.588
.467
Within group comparison: 10 min pre vs immediate post .262 .275
Within group comparison: 10 min pre vs 10 min post .183 .270
Bold print = significant correlations (P < .05).
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(40) and indicated an efficient post-exertional recovery 
in the healthy controls. ME/CFS patients showed an im-
paired HR recovery and parasympathetic reactivation 
following exercise. We hypothesized that autonomic-
mediated recovery following exercise would be as-
sociated with the magnitude of EIA. All self-reported 
pain measures indicated the presence of EIA in the HS 
group, but only the change in intensity of overall pain 
was large enough to reach significance, and therefore 
seemed the best parameter to indicate the presence of 
EIA in this study. This parameter remained unchanged 
in ME/CFS patients following exercise, indicating EIA 
did not occur, which is in line with previous observa-
tions (9). The possible relationship between presence 
or lack of EIA and autonomic functioning was explored 
using correlation analyses.
The impaired HR recovery following exercise was 
not associated with the lack of EIA in ME/CFS patients. 
However, the reduced parasympathetic reactivation 
during exercise recovery observed in ME/CFS patients 
was associated with a lack of EIA. These results suggest 
that the efficacy of autonomic recovery can possibly 
mediate the degree of (dys)function of EIA in ME/CFS 
patients.
Furthermore, the results from this study support 
the idea that arterial baroreceptor activity plays a role 
Table 3. Correlation analyses in ME/CFS and HS group.
Δ
VAS pain (muscle and/or 
joint pain) (mm)
VAS headache 
(mm)
SF-36 bodily pain
(score)
HS (post-pre) -0.8
ME/CFS (post-pre) 0.0
HS (post-pre) -0.3
ME/CFS (post-pre) 5.2
HS (post-pre) 0.8
ME/CFS (post-pre) 1.5
r P r P r P
HR 
(bpm)
HS (post-pre) 0.81 -.137 .565 .011 .964 -.393 .086
ME/CFS (post-pre) 2.48 -.190 .436 .117 .634 .257 .288
HRV RMSSD 
(ms)
HS (post-pre) 2.83 .127 .594 .058 .810 .063 .791
ME/CFS (post-pre) -4.93 .407 .084 -.357 .134 -.146 .550
HRV LF 
(ms2)
HS (post-pre) -127.00 .012 .959 .047 .845 -.102 .668
ME/CFS (post-pre) -55.03 .552 .014 -.038 .878 -.123 .616
HRV HF 
(ms2)
HS (post-pre) -5.82 .065 .787 .087 .715 .022 .926
ME/CFS (post-pre) -68.29 .226 .353 -.480 .038 -.072 .769
HRV LF/HF 
ratio 
HS (post-pre) -0.15 .235 .318 -.389 .090 -.028 .907
ME/CFS (post-pre) 0.09 -.049 .841 .287 .233 .049 .842
RR 
(/min)
HS (post-pre) 1.78 .087 .725 .030 .903 .434 .064
ME/CFS (post-pre) 2.19 -.169 .502 .079 .757 -.071 .778
Systolic BP 
(mmHg)
HS (immediate post-
10 min pre) 7.00 .004 .986 .182 .444 -.089 .709
ME/CFS (immediate 
post-10 min pre) 6.80 -.026 .914 .108 .650 .064 .790
HS (10 min post-10 
min pre) 2.95 .128 .589 .113 .636 -.193 .416
ME/CFS (10 min 
post-10 min pre) 0.60 -.149 .532 .188 .428 .110 .645
Diastolic BP 
(mmHg)
HS (immediate post-
10 min pre) 1.35 .246 .296 -.059 .804 .318 .172
ME/CFS (immediate 
post-10 min pre) 1.10 -.261 .266 .077 .747 .472 .036
HS (10 min post-10 
min pre) 1.20 .580 .007 -.164 .491 .291 .213
ME/CFS (10 min 
post-10 min pre) 1.35 -.082 .732 .049 .837 .152 .523
Bold print = significant correlations (P < .05).
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within the phenomenon of EIA. In healthy people, the 
change in pain intensity in response to exercise was as-
sociated with changes in diastolic BP. A similar observa-
tion was made in ME/CFS patients, where the change 
in the presence of bodily pain in response to exercise 
was associated with post-exertional changes in diastolic 
BP. More specifically, a poor recovery of diastolic BP in 
response to exercise, with BP remaining elevated, was 
associated with post-exertional pain reductions, which 
represents EIA. It has been previously described that the 
arterial baroreceptors are activated by increases in BP 
during exercise (14-16). A poor recovery of HF follow-
ing exercise, during which HF remains elevated, was 
associated with increased headache intensity follow-
ing exercise. In addition, a poor recovery of LF, during 
which LF remained decreased in comparison to base-
line, was associated with the lack of EIA in the muscles 
or joints in ME/CFS patients. The decrease of LF activity 
following exercise indicates that less baroreflex activity 
takes place during recovery from exercise than at rest, 
which further strengthens the theory that baroreceptor 
activation is a factor which determines the presence or 
lack of EIA.
The cardiac baroreflex sensitivity, which is the 
change in R-R interval per unit change in systolic BP, 
plays an important intermediate role between BP and 
pain (47). Preliminary evidence suggests reduced baro-
reflex sensitivity in ME/CFS patients (47), but its rela-
tionship to pain and EIA has not been studied before. 
Chronic pain appears to be characterized by alterations 
in baroreflex sensitivity as well as impairments in de-
scending inhibitory pathways and activation of pain 
faciliatory pathways (48). There is some evidence that 
central noradrenergic changes may account for the re-
duced baroreceptor sensitivity associated with chronic 
stress (49). Therefore, the stress associated with chronic 
pain may lead to similar diminished baroreceptor sensi-
tivity and thus contribute to the exaggerated pain sen-
sitivity in ME/CFS patients (50). Furthermore, oxidative 
stress has been reported to modulate baroreceptor sen-
sitivity in health and disease (51), and there are indica-
tions that the post-exertional oxidative stress response 
in ME/CFS occurs earlier and lasts longer (52-54). Taking 
this into consideration, it can be assumed that the re-
duced baroreflex sensitivity can be influenced by drugs 
which activate noradrenergic descending pathways or 
affect oxidative stress production. Furthermore, it has 
been shown that physical training causes an increase 
in parasympathetic tone (55) and thus could also be 
beneficial in ME/CFS. However, care should be taken to 
not elucidate pain exacerbations by carefully determin-
ing and monitoring the exercise intensity and provid-
ing sufficient long recovery periods. Unfortunately, 
there is currently little knowledge regarding the best 
exercise intensity for improving autonomic balance in 
ME/CFS. While drug treatments in conjunction with 
graded exercise therapy might be an option to improve 
baroreflex sensitivity and parasympathetic reactivation 
following exercise, which in theory would facilitate EIA 
to some extent, future research is necessary to examine 
whether this is the case.
Strengths and Limitations
Given the absence of previous data regarding 
the association between autonomic function during 
exercise recovery and EIA, an exploratory approach 
was used to examine this hypothesis. While this study 
provides indications for the role of parasympathetic 
and baroreflex reactivation following exercise and the 
presence and degree of EIA, the cross-sectional design 
does not allow firm conclusions regarding the causality 
of the observed relations. Although the sample size was 
limited, significant correlation coefficients ranged from 
0.36 to 0.67, representing moderate associations.
Besides these limitations, this study also had sever-
al strengths. By not limiting the study to solely healthy 
people, but also implementing a population in which 
impaired EIA has been shown, we were able to detect 
whether subtle impairments in autonomic function-
ing would be related to dysfunctional EIA. On the one 
hand, more objective measures could have been used 
to assess pain (such as evaluation of pain thresholds/
tolerance), but on the other hand, we assessed the en-
dogenous effects of exercise on clinical pain which is of 
particular relevance for patient populations such as ME/
CFS as these patients often experience post-exertional 
(increases of) pain complaints following daily physical 
activities. Both studied populations were well matched 
regarding gender, age, body mass index, and exercise 
capacity, so that these factors could not be explanatory 
for the differential group findings. Furthermore, we an-
ticipated different potential sources of bias on the days 
of the assessment. A final strength is that all measures 
took place in an acclimatized room, which is required 
for valid exercise and autonomic measurements. 
conclusion
Reduced parasympathetic reactivation during re-
covery from exercise is associated with the dysfunctional 
EIA in ME/CFS. In addition, poor recovery of diastolic BP 
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